The report assesses Polycystic Kidney Disease
therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
Potts, MD, Thoracic aortic dissection in a patient with autosomal dominant polycystic kidney disease
The picture was suggestive of polycystic kidney disease
Sonographic assessment of the severity and progression of autosomal dominant polycystic kidney disease
: The Consortium of Renal Imaging Studies in Polycystic Kidney Disease
Ambulatory blood pressure correlates with renal volume and number of renal cysts in children with autosomal dominant polycystic kidney disease
Autosomal dominant polycystic kidney disease
with anticipation and Caroli's disease associated with a PKD1 mutation.
In line with our strategy, the autosomal dominant polycystic kidney disease
diagnostic patent provides us with another excellent licensing and partnering opportunity.
For more information regarding support groups or polycystic kidney disease
, call 800-PKD-CURE (753-2873).
However, some doctors believe that low protein diets may slow the progression of kidney failure in polycystic kidney disease
GlobalData, the industry analysis specialist, has released its new report, Polycystic Kidney Disease
(PKD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019.
Professor Robin Williams, from the School of Biological Sciences at Royal Holloway, said: "This discovery is vital in helping us to understand how polycystic kidney disease
may be controlled and ultimately treated.
ClickPress, Wed May 01 2013] Polycystic Kidney Disease
- Pipeline Review, H1 2013